These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. Byers MG; Allison KM; Wendel CS; Lee JK J Clin Psychopharmacol; 2010 Jun; 30(3):225-9. PubMed ID: 20473055 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial. Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020 [TBL] [Abstract][Full Text] [Related]
24. Quetiapine alone and added to a mood stabilizer for serious mood disorders. Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770 [TBL] [Abstract][Full Text] [Related]
25. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine. Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103 [TBL] [Abstract][Full Text] [Related]
26. Atypical antipsychotics, improved intrusive symptoms in patients with posttraumatic stress disorder. Ahearn EP; Winston E; Mussey M; Howell T Mil Med; 2003 Sep; 168(9):x-xi. PubMed ID: 14529262 [No Abstract] [Full Text] [Related]
27. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder. Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357 [TBL] [Abstract][Full Text] [Related]
28. First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo. Suppes T; Ketter TA; Gwizdowski IS; Dennehy EB; Hill SJ; Fischer EG; Snow DE; Gonzalez R; Sureddi S; Shivakumar G; Cosgrove VE J Affect Disord; 2013 Aug; 150(1):37-43. PubMed ID: 23521871 [TBL] [Abstract][Full Text] [Related]
29. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. Jing Y; Kim E; You M; Pikalov A; Tran QV J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195 [TBL] [Abstract][Full Text] [Related]
30. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target. Villeneuve E; Lemelin S J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544 [TBL] [Abstract][Full Text] [Related]
31. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder. Dando TM; Keating GM Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876 [TBL] [Abstract][Full Text] [Related]
32. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Kozaric-Kovacic D; Pivac N Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162 [TBL] [Abstract][Full Text] [Related]
33. Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study. Janiri L; Martinotti G; Di Nicola M J Clin Psychopharmacol; 2007 Oct; 27(5):519-20. PubMed ID: 17873691 [No Abstract] [Full Text] [Related]
34. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. Zhornitsky S; Potvin S; Moteshafi H; Dubreucq S; Rompré PP; Stip E Int Clin Psychopharmacol; 2011 Jul; 26(4):183-92. PubMed ID: 21372722 [TBL] [Abstract][Full Text] [Related]
35. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine. Gianfrancesco F; Pesa J; Wang RH J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206 [TBL] [Abstract][Full Text] [Related]
36. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Dossenbach M; Arango-Dávila C; Silva Ibarra H; Landa E; Aguilar J; Caro O; Leadbetter J; Assunção S J Clin Psychiatry; 2005 Aug; 66(8):1021-30. PubMed ID: 16086618 [TBL] [Abstract][Full Text] [Related]
37. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder. Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397 [TBL] [Abstract][Full Text] [Related]
38. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study. El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941 [TBL] [Abstract][Full Text] [Related]
39. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128 [TBL] [Abstract][Full Text] [Related]